Herceptin Videos

As treatment with Herceptin was being modified, ultimately, the drug was going to live or die by the participation of the group of women who courageously volunteered to participate in the first clinical study.

"Living Proof" stars Harry Connick Jr. and Angie Harmon talk about the challenges that had to be overcome before the drug Herceptin, could be used to treat breast cancer patients.

Dr. Dennis Slamon and Lilly Tartikoff discuss the research and efforts that helped make his breast cancer drug a reality. Years later, survival rates are up and while there is still a ways to go, this story will hopefully inspire similar research.

Steph hanging out with me at a Herceptin treatment at the RCC...

"Living Proof is the true story of a UCLA oncologist who helped develop the breast cancer drug Herceptin. His inspring journey shows the sacrafices he made and obstacles he faced to get the drug approved. Staring Harry Connick Jr and Renee Zellweger. Premieres Oct 18th at 9pm ET/PT on Lifetime. Author: lifetimepdTags: lifetime premiere living proof harry connick jr renee zellwegger medicine cancer true story doctor Posted: 13 October 2008Rating: 0.0Votes: 0

My Last Cancer Treatment of Herceptin

A woman with breast cancer has won the right to challenge her local NHS trust's refusal to give her the drug Herceptin.

A judge is expected to decide whether a woman is eligible for a cancer drug in what may be a test case for the NHS.

A woman from Swindon is continuing her fight for the breast cancer drug Herceptin at the Court of Appeal.

Herceptin IV Medication administered

A breast cancer patient whose local NHS trust denied funding for the drug Herceptin has taken her case to the Court of Appeal.

A woman with early stage breast cancer has lost a legal bid to force an NHS trust to provide her with free Herceptin.

The Court of Appeal has ruled that breast cancer patient Ann Marie Rogers should receive the drug Herceptin.

FDA APPROVES HERCEPTIN FOR THE ADJUVANT TREATMENT OF HER2 POSITIVE NODE POSITIVE BREAST CANCER HERCEPTIN REDUCED THE RISK OF BREAST CANCER RECURRENCE BY 52 PERCENT IN PIVOTAL STUDIES ONLY TARGETED BIOLOGIC THERAPY APPROVED FOR USE IN ADJUVANT AND METASTATIC HER2 POSITIVE BREAST CANCER Genentech, Inc. announced today that the U.S. Food and Drug Administration FDA approved Herceptin Trastuzumab for the adjuvant treatment of HER2 positive node positive breast...

HERCEPTIN REDUCED THE RISK OF BREAST CANCER RECURRENCE BY 52 PERCENT IN PIVOTAL STUDIES ONLY TARGETED BIOLOGIC THERAPY APPROVED FOR USE IN ADJUVANT AND METASTATIC HER2 POSITIVE BREAST CANCER Genentech, Inc. announced today that the U.S. Food and Drug Administration FDA approved Herceptin Trastuzumab for the adjuvant treatment of HER2 positive node positive breast cancer, as part of a treatment regimen containing doxorubicin, cyclophosphamide, and paclitaxel. The FDA approval w

In "Living Proof," Harry Connick Jr. plays the role of Dr. Dennis Slamon, the real doctor who broke barriers in the field of breast cancer research with his drug Herceptin.

July 23, 2007 Insidermedicine From VancouverNewer treatments for breast cancer that has metastasized or spread elsewhere in the body can improve how long women live. Those diagnosed with the condition in the late 1990s lived 30% longer or an additional 7 months when compared to those diagnosed earlier. The effect is believed to be related to access to new medicines like Taxotere and Herceptin.From PennsylvaniaGetting tweens and teens to bed on time may keep them out of trouble. Research on

Click MOre MDAnderson Cancer .. Dr. decided put me back on Herceptin. My hospitalization occured a month after I got off it. I am feeling just great but watch everything.. Some fluid is tolerable in the lungs. Not sure how much. . I eat healthier today. Pray often. It helps. Houston Lung Heart Hospital Visit On Wednesday Aug. 29, 2007 I as given a thoracentesis by the Cardiopulmonary Center for

Click here for Korean translation of Genentech are getting a big boost after some positive results for one of its drugs. Its breast cancer treatment, Herceptin, showed promise in a trial of women with early stage cancer. The drug is already approved for treatment of the sickest breast cancer patients but the new results have raised hopes that it will be cleared for wider use. Genentech shares have performed well over the last year, thanks in part to good results f

Jane describes how Herceptin has helped her fight breast cancer, while keeping her on the golf course.